Stimulation of Natural Killer Cells with Small Molecule Inhibitors of CD38 for the Treatment of Neuroblastoma

The authors described the synthesis and biological evaluation of small molecule CD38 inhibitors and demonstrated their potential utility as a novel approach to neuroblastoma immunotherapy.